Non obstructive thrombosis after bioprosthetic mitral valve replacement
DOI:
https://doi.org/10.37615/retic.v4n2a8Keywords:
Mitral valve, thrombosis, anticoagulants.Abstract
Non-obstructive prosthetic heart valve thrombosis is an entity of increasing diagnosis in recent times. We present a 74-year-old patient with a history of severe functional mitral regurgitation who underwent a mitral-valve replacement with a biological prosthesis. During the immediate postoperative care, a transesophageal echocardiogram was performed with evidence of the left atrial thrombus close to the bioprosthesis in the absence of an increased transprosthetic gradient. In this context, anticoagulant treatment with heparin was decided, followed by antivitamins K, with good evolution.
Downloads
Metrics
References
Mutuberría-Urdaniz M, Rodríguez-Palomares JF, Ferreira I, Bañeras J, Teixidó G, Gutiérrez L et al. Nonobstructive prosthetic heart valve thrombosis (NOPVT): really a benign entity? Int J Cardiol. 2015; 197:16–22. doi: https://doi.org/10.1016/j.ijcard.2015.06.021 DOI: https://doi.org/10.1016/j.ijcard.2015.06.021
Laplace G, Lafitte S, Labèque JN, Perron JM, Baudet E, Deville C, et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: A postoperative monocentric study of 680 patients. J Am Coll Cardiol. 2004; 43(7):1283–90. doi: https://doi.org/10.1016/j.jacc.2003.09.064 DOI: https://doi.org/10.1016/j.jacc.2003.09.064
M. Lengyel, G. Vegh, L. Vandor, Thrombolysis is superior to heparin for nonobstructive mitral mechanical valve thrombosis. J. Heart Valve Dis. 1999; 8(2):167–73.
Gürsoy MO, Kalçık M, Karakoyun S, Özkan M. The current status of fluoroscopy and echocardiography in the diagnosis of prosthetic valve thrombosis-a review article. Echocardiography 2015; 32(1):156–64. doi: https://doi.org/10.1111/echo.12721 DOI: https://doi.org/10.1111/echo.12721
Gürsoy MO, Kalçık M, Yesin M, Karakoyun S, Bayam E, Gündüz S, Özkan M. A global perspective on mechanical prosthetic heart valve thrombosis: diagnostic and therapeutic challenges. Anatol J Cardiol. 2016. 16;12: 980–989. doi: https://doi.org/10.14744/AnatolJCardiol.2016.7486 DOI: https://doi.org/10.14744/AnatolJCardiol.2016.7486
A.T. Tong, R. Roudaut, M.Ozkan, et al. Prosthetic Valve Thrombolysis - Role of Transesophageal Echocardiography (PRO-TEE) Registry investigators. Transesophagealechocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry, J. Am. Coll. Cardiol. 2004; 43(1):77–84.doi: https://doi.org/10.1016/j.jacc.2003.08.028 DOI: https://doi.org/10.1016/j.accreview.2004.03.002
Baumgarther H, Falk V, Bax J, De Bonis M, Hamm C, Holm P, et al. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías. Rev Esp Cardiol. 2018; 71(2):110:1-47. doi: https://doi.org/10.1016/j.recesp.2017.12.014 DOI: https://doi.org/10.1016/j.recesp.2017.12.014
Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, et al. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic Mechanical valve Thrombosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial. Am Heart J 2015; 170(2):409-418. doi: https://doi.org/10.1016/j.ahj.2015.04.025 DOI: https://doi.org/10.1016/j.ahj.2015.04.025
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Sebastián Juan Bautista Mrad, Virginia Barba, Luciano Fallabrino, Antonio Piazza, Raúl Ferreira
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
